Condition
Type 1 Diabetes
Type 1 diabetes is an autoimmune condition in which the immune system destroys the pancreas cells that make insulin, so blood sugar climbs. For blood glucose, trials of saffron and magnesium found improvements, though the evidence is moderate for saffron and limited for magnesium. Studies were small, and some included people with type 2 diabetes, so insulin remains essential and these results are a rough guide.
Sources: PMID 39818282; PMID 34836329
- Supplements studied
- 17
- Medicines and peptides
- 1
- Graded outcomes
- 15
- Trials
- 22
- People studied
- 8,316
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Glycemic Control Small Improvement | Improves (the measure goes up) | Small effect | 64 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 87 people | |||
Beta-Alanine
- Beta-cell function: worsens
- Blood glucose: changes; see studies
- HbA1c: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Beta-cell function Small Decrease | Worsens (the measure goes down) | Small effect | 82 people | |||
| Blood glucose | Changes; see studies | 1 study | 172 people | |||
| HbA1c | Changes; see studies | 134 people | ||||
| Insulin | Changes; see studies | 82 people | ||||
| Insulin Resistance | Changes; see studies | 82 people | ||||
Magnesium
- Blood glucose: improves
- Blood Pressure: improves
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 17 studies | 79 people | ||
Studies that measured blood glucose
| ||||||
| Blood Pressure | Improves (the measure goes down) | 10 studies | 79 people | |||
Studies that measured blood pressure
| ||||||
| Triglycerides | Improves (the measure goes down) | 2 studies | 79 people | |||
| Diabetic Neuropathy Symptoms | Improves (the measure goes down) | 1 study | 97 people | |||
Studies that measured diabetic neuropathy symptoms | ||||||
| LDL Oxidation | Improves (the measure goes down) | 1 study | 11 people | |||
Studies that measured ldl oxidation | ||||||
| HbA1c | Improves (the measure goes down) | 79 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 79 people | ||||
| Weight | Improves (the measure goes down) | 79 people | ||||
Chromium
- Blood glucose: improves
- Weight: improves
- Glycemic Control: improves
L-Carnitine
- Blood glucose: improves
- Diabetic Neuropathy Symptoms: improves
- HbA1c: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 5 studies | 232 people | ||
Studies that measured blood glucose
| ||||||
| Diabetic Neuropathy Symptoms | Improves (the measure goes down) | 1 study | 232 people | |||
Studies that measured diabetic neuropathy symptoms | ||||||
| HbA1c | Improves (the measure goes down) | 1 study | 232 people | |||
Coenzyme Q10
- Blood glucose: improves
- Blood Pressure: improves
- Low-density lipoprotein (LDL): improves
Vitamin E
- Blood Flow
- LDL Oxidation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Mixed effect | 2 studies | 41 people | ||||
| LDL Oxidation | Improves (the measure goes down) | 41 people | ||||
Zinc
- Blood glucose: improves
- HbA1c: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 10 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 10 people | |||
Studies that measured hba1c | ||||||
| Insulin | Changes; see studies | 1 study | 10 people | |||
| Insulin Resistance | Improves (the measure goes down) | 10 people | ||||
Taurine
- Blood Flow: improves
- Blood Pressure: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Moderate Increase | Improves (the measure goes up) | Moderate effect | 19 people | |||
| Blood Pressure | Improves (the measure goes down) | 3 studies | 19 people | |||
Studies that measured blood pressure
| ||||||
| Heart Rate | Improves (the measure goes down) | 19 people | ||||
Vitamin C
- Aerobic Exercise Metrics
- HbA1c: improves
- Oxidative Stress Biomarkers: improves
Fish Oil
- C-Peptide
- HbA1c: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Peptide No effect | NoneNo effect | 1 study | 90 people | |||
| HbA1c | Improves (the measure goes down) | 2 studies | 90 people | |||
Studies that measured hba1c
| ||||||
Benfotiamine
- HbA1c
- High-density lipoprotein (HDL)
- Nerve Repair: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| HbA1c No effect | NoneNo effect | 67 people | ||||
| High-density lipoprotein (HDL) No effect | NoneNo effect | 67 people | ||||
| Nerve Repair | Improves (the measure goes up) | 1 study | 67 people | |||
| Inflammation | Changes; see studies | 67 people | ||||
| Total cholesterol | Changes; see studies | 67 people |
Vitamin D
- Type 1 Diabetes Incidence: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Type 1 Diabetes Incidence | Changes; see studies | 1 study | 51 people |
D-Ribose
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose | Improves (the measure goes down) | 1 study | 34 people |
Resveratrol
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Glycemic Control | Improves (the measure goes up) | 1 study | 10 people |
Bromelain
- Type 1 Diabetes Incidence: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Type 1 Diabetes Incidence | Changes; see studies | 1 study | 20 people |
Prescription medicines and peptides studied, for context
Pramlintide (Symlin)
- HbA1c Reduction (Type 1): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| HbA1c Reduction (Type 1) FDA-approved for type 1 diabetes. Long-term studies show HbA1c and weight reduction without increased severe hypoglycemia. | Improves (the measure goes down) | Moderate effect | 28 studies |
Key findings
- Blood glucoseImproves (the measure goes down)
- Glycemic ControlImproves (the measure goes up)
- Beta-cell functionWorsens (the measure goes down)
The Type 1 Diabetes (Supportive Care) protocol
2 primary supplements · 2 supporting supplements
- Vitamin D2,000–4,000 IU daily (target 40–60 ng/mL)
- Omega-3 Fatty Acids2–3 g EPA/DHA daily
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Type 1 Diabetes. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
The supplements graded A or B for Type 1 Diabetes. Each opens third-party tested products for that supplement.
- Grade B
- Grade B
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
2 studies from PubMed
- Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trial
- A one-week reduced-carbohydrate diet to mitigate iatrogenic peripheral hyperinsulinemia does not improve insulin sensitivity or endothelial function in a randomized, crossover trial in patients with type 1 diabetes.